fda compounding semaglutide news october 2025 US sends 25 letters to telehealth companies over claims on compounded weight-loss drugs Compounded Semaglutide & Tirzepatide 2025:

Important: Prescription GLP-1 treatments require medical supervision, involve injections, and come with potential side effects

Half took semaglutide once weekly, the other took a placebo

Researchers examining inflammatory disease models, gut epithelial biology, or mucosal immunity alongside tissue repair endpoints choose KLOW

They are not approved by the FDA and are not intended for human or veterinary use, clinical applications, diagnostic procedures, or therapeutic treatment of any kind

According to research in Clinical Endocrinology , it's also growth hormone-dependent and provides additional information about growth hormone status